Specifically, this analysis indicated that TRIM8 expression was higher in leukemia and prostate cancer, but was lower in breast cancer, esophageal cancer, lung cancer, melanoma, and sarcoma (Figure 2A). This evidence concerns the gene TRIM8 and breast cancer.